Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

This study has been terminated.
(Difficulties in completing the required sample size)
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Fundación Cardiovascular de Colombia
ClinicalTrials.gov Identifier:
NCT00319202
First received: April 26, 2006
Last updated: November 2, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2012
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)